# GPT-5.2 Review

**Role:** External referee review
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-03T19:35:28.164411
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 21367 in / 4868 out
**Response SHA256:** 8b8cb206fff4a58f

---

## Summary

The paper exploits arXiv’s daily 14:00 ET cutoff in a sharp RDD to estimate the *net* causal effect of (i) a large improvement in listing position (≈70 percentile points) bundled with (ii) a one-business-day announcement delay, on downstream “adoption” by frontier AI labs (citations from Google/DeepMind, OpenAI, Meta/FAIR, Anthropic, xAI). The design is intuitive and the first stage is strong; main estimates are near zero and statistically insignificant for frontier adoption, adoption speed (Cox hazard), and general citations. The paper is transparent about limited power.

Scientifically, the core question is interesting and policy-relevant. Publication readiness, however, is limited by (a) severe effective-sample constraints for rare adoption outcomes, (b) important unresolved threats related to strategic timing/manipulation and compound treatment interpretation, and (c) incomplete validation of the frontier-adoption measurement pipeline and sample construction (especially matching/attrition and affiliation classification). I view the project as *salvageable*, but it likely needs either (i) a meaningfully expanded dataset / higher-power outcome strategy, or (ii) a reframing to a tight “null-with-bounds” contribution supported by stronger measurement validation and sharper interpretation.

---

## 1. Identification and empirical design (critical)

### 1.1 RDD concept is plausible, but manipulation/selection needs a stronger treatment
- The institutional cutoff is real and mechanically assigns batch/listing order (Sections 2–5). The first stage is very large (Figure 2; Table A.1 Panel A).
- You acknowledge a visible spike just after the cutoff (Figure 1) while reporting a non-rejection in the formal density test (Appendix “McCrary Density Test,” p-values ~0.67).

**Concern:** In RD, *non-rejection* in a density test is not evidence of no manipulation, especially with modest effective sample sizes near the cutoff and when strategic timing is common knowledge in the community (you cite Haque et al.). The visible spike suggests sorting. If authors who deliberately submit just after 14:00 differ in unobservables (quality, “marketing-savviness,” lab connections), continuity of potential outcomes may fail.

**What you do now:** Donut RDD (Table 6 Panel B) and covariate balance (Table 2) help, but they do not fully resolve sorting on unobservables.

**What’s missing / should be added:**
- A clearer statement of *which* identification condition you rely on under possible manipulation. The text gestures at Lee (2010) continuity and Gerard (2020) “complier” interpretation, but you need to make the estimand and assumptions explicit: is this (i) a standard continuity-based RD with mild sorting allowed, or (ii) a local-randomization design within a small window? These are different inferential frameworks and imply different diagnostics and estimation choices.
- Stronger evidence that strategic timers are not higher-quality *around the cutoff*, e.g.:
  - Pre-treatment proxies more directly tied to quality (institution rank of authors at posting; prior citation record of authors; whether the paper is cross-posted to high-volume categories; presence of code link; length of references—if obtainable; later acceptance at major venues if you can match).
  - Tests for discontinuities in *ex ante* author prominence (OpenAlex author IDs / h-index proxies) right at the cutoff.

### 1.2 Compound treatment: interpretation is coherent but the paper sometimes slides toward “visibility” conclusions
You are explicit that the cutoff bundles **position improvement + announcement delay** and that you estimate a reduced-form *net* effect (Introduction; Discussion; Conclusion). That is good.

**However**, several interpretive passages still read like they are testing “visibility effects” per se (e.g., “moved from near-invisibility to maximum visibility” in Results; and some policy implications about randomization). A net-zero reduced-form does **not** imply the visibility effect is zero; it could be positive and offset by delay.

**Needed:** tighter calibration of claims throughout:
- When you say “visibility on a preprint server appears to be a weak force,” that is only supported if you can show the delay penalty is small or separately bounded. Otherwise the supported claim is: “the *tradeoff* induced by submitting after the cutoff (better position but later announcement) does not increase frontier adoption.”

A promising way forward is to *bound* the visibility effect under plausible assumptions about the delay cost, or to use settings where the delay cost differs (e.g., Thursday vs other days) in a way that maps more sharply into a two-component model.

### 1.3 Treatment timing and heterogeneous “dose” across weekdays is underexploited and potentially confounding
You note that Thursday submissions have multi-day front-page exposure (Figure 1 timeline; heterogeneity in Appendix Table A.5). This is potentially powerful, but right now it is used only as a low-power subgroup check.

**Issue:** The “delay” component also varies by day (e.g., Thu cutoff → Sun announcement; Fri cutoff → Mon announcement), and the “visibility” component may vary with batch size and reader behavior across weekdays. This heterogeneity is not only an opportunity; it is also a threat if the composition of submitters differs systematically by day-of-week near 14:00 (conference deadlines, work schedules).

**Needed:**
- A cleaner mapping of the day-of-week schedule into a measurable “announcement delay” variable (in hours) and an “exposure duration” variable (hours on front page), and then either:
  1) an interacted RD (treatment × delay/exposure), or
  2) a pooled model that uses predicted delay/exposure as moderators, with careful interpretation and multiple-testing control.
  
This could help partially separate the two mechanisms (position vs delay) or at least show whether the net effect changes when the delay is much larger (Thu/Fri) versus small (Mon–Wed).

### 1.4 Running variable construction: DST and timestamp definitions need explicit validation
You convert UTC timestamps to Eastern Time and compute minutes from 14:00 ET (Data section). This is fine, but there are two practical concerns that matter for RD validity:
- **Daylight Saving Time transitions:** if your conversion is imperfect around DST boundaries, you can misclassify which side of the cutoff a submission belongs to, creating a fuzzy/attenuated RD and potentially non-classical error if errors cluster.
- **Which timestamp is used:** arXiv has “submittedDate” and may have versioning; you should confirm you use the first submission timestamp (v1) and that it corresponds to the cutoff rule.

**Must add:** a short validation appendix: how ET conversion is done (library, timezone database), how DST days are handled, and a diagnostic showing no mechanical anomalies around DST transition weeks.

---

## 2. Inference and statistical validity (critical)

### 2.1 RD inference: rdrobust is appropriate, but binary rare outcomes + tiny effective N require additional finite-sample discipline
You use Calonico-Cattaneo-Titiunik robust bias-corrected RD inference (Section 5; Tables 3–6). This is the right baseline.

**Problem:** The effective sample for the main specification is **86** observations (e.g., Table 3) with a baseline adoption rate ≈ 5%. That means only ~4–5 “successes” per side in expectation for the 18-month outcome; in practice the event count is extremely small.

With such discreteness, asymptotic approximations can be fragile even with RBC. You partially address this with randomization inference (RI) p-values (Table 6 Panel C), but:
- RI is reported only for two outcomes, not systematically for the primary frontier outcomes in Table 3 and the full set of citation outcomes in Table 5.
- Power/MDE is discussed, which is good, but **confidence intervals** should be emphasized more than p-values given the design’s limited resolution.

**Must-fix:**
- Report **RI p-values (and ideally RI-based CIs)** for *all primary outcomes* in Table 3, not selectively.
- Provide **exact event counts** by side of cutoff within the main bandwidth for each binary outcome (e.g., how many frontier-adopted events left vs right). Right now the reader cannot assess discreteness severity.

### 2.2 Cox model within the RD window is likely underpowered and potentially unstable
Table 4 reports Cox estimates with only **14 events** for frontier labs and 28 for any industry. With such event counts, Cox partial likelihood can be unstable; standard errors rely on asymptotics that may be poor, and the proportional hazards assumption cannot be meaningfully tested.

**Needed:**
- At minimum, report a simple nonparametric comparison (e.g., Kaplan–Meier within bandwidth) and/or a **discrete-time hazard** model with penalization.
- Consider **Firth penalization** / bias reduction for rare events (or at least discuss small-event bias).
- Report sensitivity of hazard estimates to widening bandwidths (the Cox model is currently tied to the MSE bandwidth from a different outcome).

### 2.3 Multiple outcomes and multiple specifications: risk of selective emphasis
You present many outcomes (adoption within 18m, ever by 2026, number of labs, multiple citation horizons, Cox, many robustness checks). This is fine, but top journals will expect a clear “primary estimand(s)” and a control of false discovery or a clear statement that inference is descriptive across families.

**Needed:** pre-specify primary outcomes in a compact way and either:
- adjust for multiple testing within outcome families (at least report q-values), or
- state explicitly that secondary outcomes are exploratory and interpret accordingly.

### 2.4 Consistency of sample sizes and attrition needs to be tightened for inferential credibility
There are internal inconsistencies/ambiguities that are scientifically important:
- You state you start with ~50,000 papers and have a “combined match rate ~40%, yielding 1,845 matched papers” (Data section). 40% of 50,000 would be ~20,000, not 1,845. So either:
  - 1,845 is the matched sample **within the near-cutoff window** (or another restricted subsample), or
  - the 50,000 number is incorrect for the categories/period queried, or
  - the “40% match rate” is incorrect for the analysis sample.
  
This matters because the credibility of adoption measurement and external validity depends on understanding what is lost in matching and why.

**Must-fix:** A transparent sample flow table (not exhibit-design QA; substantively: you need the counts) showing:
1) total arXiv papers by category-year,
2) papers with usable timestamps,
3) papers within ±120 minutes,
4) matched to Semantic Scholar,
5) matched to OpenAlex citing works with affiliations,
6) included for each horizon-specific outcome,
7) included in the final bandwidth-specific RD estimation.

Also include a discontinuity test for “matched to OpenAlex affiliation data” at the cutoff (you say “verify smooth at cutoff,” but no table is shown).

---

## 3. Robustness and alternative explanations

### 3.1 Robustness within the chosen framework is good but not decisive against sorting
Bandwidth sensitivity (Table 6 Panel A) and donut RD (Panel B) are reassuring insofar as the estimate stays near zero. Kernel/polynomial sensitivity (Appendix Table A.6) is also fine.

**But** if sorting is important and correlated with unobserved quality, stable near-zero effects could arise from offsetting selection and treatment effects. This is not just theoretical: you observe a post-cutoff spike consistent with strategic behavior.

**Recommended robustness:**
- Use “donut + covariates” (include covariates in rdrobust) and show stability.
- Show results using a **local randomization** approach within a very narrow window (e.g., ±10 minutes) and conduct Fisherian randomization inference under that design. This aligns better with the “as-good-as-random” narrative you use in parts of the paper.

### 3.2 Measurement robustness for “frontier adoption” is not yet adequate
Your key outcome depends on:
1) OpenAlex coverage of citing works,
2) accurate extraction of affiliations,
3) substring matching of institutions,
4) defining “frontier lab citation” as “any author affiliated with X”.

Potential issues:
- **False negatives:** missing affiliations; subsidiaries; “DeepMind Technologies Limited”; “Google LLC” vs “Google Research”; lab names in non-English; authors with dual affiliations where industry is omitted.
- **False positives:** “Meta” as a substring; “FAIR” in contexts not related to Meta; “Alphabet” used in other contexts; “xAI” string collisions.
- **Definition validity:** adoption as *citation by lab-affiliated authors* may miss genuine adoption via internal reports, code use, blogposts, or product integration; even within papers, lab researchers often publish with academic affiliations only.

**Concrete fixes:**
- Report precision/recall estimates from a manually labeled audit sample of citations classified as frontier vs not.
- Show robustness to alternate classification rules (e.g., require the *corresponding author* or *first/last author* to be frontier; or require ≥2 frontier-affiliated authors; or restrict to papers whose venue is arXiv+conference).
- Show whether results change if you use *only* OpenAlex citations (not max(OpenAlex, Semantic Scholar)) to avoid mixing measurement systems.

### 3.3 Alternative explanation: “announcement delay dominates visibility benefit” is plausible but unquantified
You interpret negative point estimates as possibly reflecting delay outweighing visibility. This is plausible and actually an important scientific insight.

But the paper currently cannot distinguish:
- “visibility has ~0 effect and delay has ~0 effect,” vs
- “visibility increases adoption but delay decreases it by a similar amount.”

**Suggestion:** Use the day-of-week variation to parameterize delay in hours and estimate whether effects are more negative when the delay is larger (Thu/Fri). Even if underpowered, a structured specification with pooled data may be more informative than subgroup splits.

---

## 4. Contribution and literature positioning

### 4.1 Contribution is potentially interesting but currently reads as “well-executed null with low power”
The novelty is the frontier-lab adoption outcome and the causal RD design at arXiv’s cutoff. That is a legitimate contribution.

However, for AER/QJE/JPE/Ecta/ReStud, you likely need at least one of:
- stronger power / sharper bounds that can rule out policy-relevant effects,
- richer outcomes closer to the mechanism (views/downloads/email clicks/social mentions),
- or a more general conceptual/method contribution (e.g., validated method for tracing industry adoption from bibliometrics).

### 4.2 Missing or underused related literature (suggest additions)
On RD under manipulation/sorting:
- McCrary (2008) classic density test citation is implicit; but discuss more recent views on sorting/identification and local randomization.
- Gerard, Rokkanen (various) on RD with manipulation/selection and “donut” logic; you cite Gerard (2020) but could position more precisely.

On staggered attention / information frictions in science-of-science:
- Work on algorithmic feeds and attention allocation in academic contexts (platform design beyond NBER digest).
- Work on preprint diffusion and social media amplification in ML/AI specifically (there is a growing bibliometrics literature).

On measuring industry adoption:
- Papers using patent citations / corporate publications / code dependencies as adoption measures could help justify why “citation by frontier lab” is an appropriate proxy and what it misses.

(You do cite Jones 2009; Bloom et al. 2020; Feenberg et al. 2017; Haque et al. 2009/2010; Merton 1968; etc. The gap is more about *validating bibliometric adoption measures* and *RD under sorting*.)

---

## 5. Results interpretation and claim calibration

### 5.1 “Precisely estimated null” is overstated for the main outcomes
Given Table 3 MDEs (0.073 vs control mean 0.053 for 18m adoption; effective N 86), the estimates are **not** “precise” in the sense relevant to frontier adoption. The design is informative about *very large* effects; it is not informative about moderate ones.

A more accurate summary:
- The first stage is precise and large.
- The reduced-form effects are centered near zero with wide intervals; you can rule out only very large net effects.

### 5.2 Policy implications should be more conditional
The policy section discusses randomization and recommendation algorithms. These are reasonable ideas, but your empirical variation does **not** identify the effect of “randomizing position holding announcement timing fixed,” which is the main actionable platform design lever. You acknowledge this in places, but it needs to be the dominant framing to avoid overreach.

---

## 6. Actionable revision requests (prioritized)

### 1) Must-fix issues before acceptance
1. **Clarify and correct sample construction/match-rate arithmetic**
   - **Why it matters:** Internal inconsistencies (50,000 → 1,845 with “40% match”) undermine credibility and prevent assessment of selection/attrition bias.
   - **Fix:** Add a full sample flow with counts at every step and correct the match-rate language; show cutoff-smoothness tests for being matched (OpenAlex + affiliations) and for being included in each outcome.

2. **Strengthen identification discussion under evident sorting**
   - **Why:** Visible post-cutoff spike suggests strategic timing; covariate balance on a few variables is not enough.
   - **Fix:** Explicitly choose an identification framework (continuity-based RD vs local randomization). Add stronger quality-proxy balance tests (author prominence, affiliations, prior publications) and/or present a local-randomization design within a narrow window with Fisher RI.

3. **Upgrade inference for rare binary outcomes and small effective N**
   - **Why:** With ~86 observations and ~5% adoption, asymptotic inference can mislead; Cox model has too few events.
   - **Fix:** Report event counts by side; add RI p-values (and ideally RI-based intervals) for *all* primary outcomes; consider exact/binomial-based or permutation-based inference for the main binary outcomes; for Cox, provide an alternative small-sample approach or clearly demote it to exploratory.

4. **Validate frontier-lab adoption measurement**
   - **Why:** The headline contribution depends on accurate classification of frontier citations.
   - **Fix:** Manual audit with estimated misclassification rates; robustness to alternative matching/classification rules; show smoothness at cutoff of key measurement components (e.g., “has OpenAlex citing works with affiliations”).

### 2) High-value improvements
5. **Exploit weekday variation structurally to speak to “delay vs visibility”**
   - **Why:** This is the central scientific ambiguity of the compound treatment.
   - **Fix:** Build a simple model where treatment intensity includes (i) announcement delay in hours and (ii) exposure duration; estimate interactions or pooled moderation rather than only subgroup splits.

6. **Reframe contribution as bounding/net-effect evidence unless power is improved**
   - **Why:** Top journals will be skeptical of a low-powered null unless it delivers sharp bounds or a broader dataset.
   - **Fix:** Either expand categories beyond AI/ML (or include all cs.*) to increase near-cutoff sample size/events, or explicitly present the paper as delivering credible bounds on large effects and validate that these bounds are policy-relevant.

7. **Tighten claims to match what is identified**
   - **Why:** Avoid overinterpreting net-zero as “visibility irrelevant.”
   - **Fix:** Systematically replace visibility-language conclusions with “net effect of submitting after cutoff,” unless you provide separation/bounds.

### 3) Optional polish (substance-level, not prose)
8. **Pre-specify outcome families and address multiple testing**
   - **Fix:** Declare Table 3 outcomes as primary; present q-values or clearly label others exploratory.

9. **DST/timestamp validation appendix**
   - **Fix:** Show no anomalies around DST transition weeks and confirm v1 timestamp use.

---

## 7. Overall assessment

### Key strengths
- Clear institutional discontinuity with a very strong first stage (≈70 percentile-point position shift).
- Appropriate baseline RD tooling (rdrobust with RBC, bandwidth sensitivity, donut RD).
- Novel and policy-relevant downstream outcome concept (frontier-lab adoption).
- Transparency about power limitations via MDE reporting.

### Critical weaknesses
- Effective sample size is too small for rare-event adoption outcomes; “precisely estimated null” is not supported.
- Sorting/manipulation concerns are visible in the density plot and not resolved with sufficiently rich balance tests.
- Frontier adoption measurement and matching/attrition pipeline are not validated to the standard required for a headline contribution.
- Cox/survival component is currently too underpowered and methodologically fragile (14 events).

### Publishability after revision
Potentially publishable if the paper either (i) substantially strengthens dataset size and measurement validation to deliver tighter bounds, or (ii) reframes as a carefully bounded net-effect study with rigorous small-sample inference and strong evidence against sorting and measurement artifacts. In its current form, it is not ready for a top general-interest outlet.

DECISION: MAJOR REVISION